Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors-Reference-Cited by-同舟云学术

Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors

Published:2004-10 Issue:10 Volume:95 Page:822-827
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Oji Yusuke,Suzuki Tsuyoshi,Nakano Yoko,Maruno Motohiko,Nakatsuka Shin-ichi,Jomgeow Tanyarat,Abeno Sakie,Tatsumi Naoya,Yokota Asumi,Aoyagi Sayaka,Nakazawa Tsutomu,Ito Ken,Kanato Keisuke,Shirakata Toshiaki,Nishida Sumiyuki,Hosen Naoki,Kawakami Manabu,Tsuboi Akihiro,Oka Yoshihiro,Aozasa Katsuyuki,Yoshimine Toshiki,Sugiyama Haruo

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2004.tb02188.x/fullpdf

Reference39 articles.

1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

3. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour

4. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

5. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation and evaluation of cancer binding capacity of HLA-A2-WT1 complex-targeting antibody;Immunology Letters;2024-08

2. WT1 targeting multi-epitope vaccine design for glioblastoma multiforme using immuno-informatics approaches;2024-06-24

3. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors;Exploration of Targeted Anti-tumor Therapy;2024-05-21

4. Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms;Molecular Biology Reports;2024-04-20

5. Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium;BMJ Open;2024-03